WeVote

Bill

Bill

SB 392

Site cleanup guidelines; residential property and other buildings used for illicit drugs.

2026 Regular Session Introduced by Emily Jordan and 1 co-sponsor

SB 392 establishes cleanup standards for residential and commercial properties contaminated by illicit drug manufacturing, addressing health risks and remediation responsibility.

Referred to Committee on Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 392

Legislative bill overview

SB 392 establishes cleanup and remediation guidelines for residential properties and buildings where illicit drugs have been manufactured, distributed, or used. The bill creates standards for property owners, law enforcement, and relevant agencies to follow when addressing contamination from drug operations, particularly focusing on methamphetamine labs and fentanyl residue.

Why is this important

Properties contaminated by drug manufacturing operations pose serious health risks to occupants and future residents due to toxic chemical residues, structural damage, and environmental hazards. Clear cleanup guidelines ensure properties are safely remediated before reoccupancy, protecting public health and establishing who bears responsibility for expensive decontamination costs. This addresses a growing public health concern as illegal drug production has increased in residential areas.

Potential points of contention

  • Cost allocation: Unclear whether property owners, law enforcement, insurance companies, or the state bear cleanup expenses, which can exceed $10,000-$30,000 per property
  • Standards stringency: Guidelines could be too prescriptive (increasing costs for owners) or too lenient (leaving health hazards unaddressed)
  • Landlord liability: Rules may disproportionately affect property owners who were unaware of tenant drug activity, raising fairness concerns
  • Implementation authority: Ambiguity about which agencies enforce compliance and what penalties exist for non-compliance

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.